09/05/2012 - £180 Million Biomedical Catalyst Fund Launched for SMEs and Academics
The Biomedical Catalyst scheme has been set up to provide funding for businesses and academics to develop solutions to healthcare challenges in the UK.
Innovative ideas are being invited from sectors or disciplines that demonstrate the potential to provide significant positive healthcare and economic impact.
The programme will support those opportunities which demonstrate the highest scientific and commercial potential, irrespective of medical area.
There is an overall budget of £180 million of grant funding available. Funding levels vary according to the grant category applied for (feasibility, early-stage and late-stage categories), up to a maximum of £2.4 million.
Support is available for projects arising from any sector or discipline aimed at addressing healthcare challenges. Example solutions may include (but are not limited to):
- stratified healthcare (both therapy and diagnostic components);
- regenerative medicine;
- eHealth and mHealth solutions; and
- enabling medical technologies and devices.
The scheme is open to applications from innovative small and medium-sized enterprises (SMEs) and academics in the UK that are undertaking research and development, either individually or in collaboration.
Three funding rounds have been announced. The deadline for registrations to the first round, which is now open, is 21 June 2012. Full applications must be received by 28 June 2012.
Click here for more information (opens in new window).
Source: Technology Strategy Board, 08/05/2012
News provided by j4bgrants.co.uk.